Ivuxolimab
Ivuxolimab Uses, Dosage, Side Effects, Food Interaction and all others data.
Ivuxolimab is under investigation in clinical trial NCT02554812 (A Study of Avelumab in Combination With Other Cancer Immunotherapies in Advanced Malignancies (JAVELIN Medley)).
| Trade Name | Ivuxolimab |
| Generic | Ivuxolimab |
| Ivuxolimab Other Names | Anti-OX40 Antibody PF-04518600, Ivuxolimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Ivuxolimab
